Carlyle Group Inc. (CIK: 0001527166) is a financial institution headquartered at C/O The Carlyle Group, 1001 Pennsylvania Avenue, N.W., Washington, District Of Columbia 20004. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.
As of the latest reporting period (2026-03-31), the institution manages a portfolio valued at $10.62 B, comprising 20 distinct securities. Over its filing history, it has submitted 63 Form 13F reports.
To view the institution’s full SEC filing history:
🔗 View All SEC Filings
Q1 2026 — Top-10 concentration: 99.9%. ▲ 1 new, +0 added, −2 reduced, ×1 exited.
| Name | Shares | Market Value | Weight | Change | Activity |
|---|---|---|---|---|---|
| 187.08 M | $8.33 B | 78.40% | ▼ 28,219,323 | Reduce -13.1% | |
| 84.59 M | $2.18 B | 20.58% | ▼ 68,086,856 | Reduce -44.6% | |
| 3.5 M | $38.85 M | 0.37% | |||
| 2.36 M | $22.3 M | 0.21% | |||
| 664,100 | $16.5 M | 0.16% | |||
| 220,500 | $8.08 M | 0.08% | |||
| 1.1 M | $7.08 M | 0.07% | |||
| 6.23 M | $4.95 M | 0.05% | |||
|
Spruce Biosciences
N/A
|
38,620 | $2.52 M | 0.02% | ||
| 107,214 | $1.79 M | 0.02% |